PerkinElmer, NCDS Collaborate on Personalized Medicine | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer and the National Center for Drug Screening are collaborating on the creation of a personalized drug research and development platform for patients in China, PerkinElmer announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.